3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Status
Completed
14
Terminated
4
Unknown
3
Recruiting
2
Active not recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Urinary Bladder Neoplasms
3
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Oligospermia
1
Non-Muscle Invasive Bladder Neoplasms
1
Fibrosis
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Gemcitabine
7
Cystectomy
5
Cisplatin
5
durvalumab
4
Neoadjuvant Therapy
4
Mitomycin
4
atezolizumab
3
Transurethral Resection of Bladder
3
Nivolumab
3
Epirubicin
3
Chemoradiotherapy
3
BCG Vaccine
3
Anesthesia, Spinal
3
tislelizumab
2
disitamab vedotin
2
catumaxomab
2
Vitamin E
2
Urinary Diversion
2
Sunitinib
2
Selenium
2
Robotic Surgical Procedures
2
Multiparametric Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Immunohistochemistry
2
Fentanyl
2
Docetaxel
2
Diathermy
2
Cystoscopy
2
Chemoprevention
2
BCG Connaught
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
Urinary Bladder Neoplasms
×
BCG Vaccine
×
Clear all
NCT02948543
2023-06-18
BCG+MM
University of Sydney
Phase 3
Unknown
501 enrolled
NCT03664869
2021-04-01
FB10
Turku University Hospital
Phase 3
Unknown
300 enrolled
NCT03790384
2018-12-31
MITOBCG
Azienda Ospedaliera "Sant'Andrea"
Phase 4
Unknown
140 enrolled